JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

RETINA - THE JOURNAL OF RETINAL AND VITREOUS DISEASES is a premier peer-reviewed journal dedicated to advancing the knowledge and practice of retinal and vitreous disorders. Published by LIPPINCOTT WILLIAMS & WILKINS, this esteemed journal boasts a significant impact factor, affirming its standing in the academic community. With a long history of publication since 1981, its scope covers cutting-edge research and innovations aimed at improving patient outcomes in ophthalmology. As evidenced by its recent categorization in the Q1 quartile for both Medicine (miscellaneous) and Ophthalmology in 2023, the journal ranks impressively, placing it in the 84th percentile among its peers. Researchers, clinicians, and students will find valuable insights and evidence-based articles that contribute to the ever-evolving landscape of retinal health. RETINA remains committed to fostering an environment for scholarly dialogue and dissemination of knowledge, ensuring its readers are at the forefront of advancements in their field.

CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

ACTA OPHTHALMOLOGICA, published by Wiley, is a premier academic journal dedicated to advancing the field of ophthalmology and related medical disciplines. Established in 1923 and maintaining esteemed status through converged years until 1994, and then from 2008 to the present, this journal has consistently delivered pioneering research, reviews, and clinical advancements essential for both practitioners and researchers in eye care. With an impressive impact factor and ranking within the top 15 of its category, ACTA OPHTHALMOLOGICA stands as a Q1 journal in both Medicine (Miscellaneous) and Ophthalmology, reflecting its significant contribution to the field. Although it is not an open-access journal, it continues to offer valuable insights and empirical findings that inform clinical practices and innovative research approaches. As such, it remains a vital resource for scholars, clinicians, and students keen to stay at the forefront of ophthalmological science.

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.

The International Journal of Retina and Vitreous, published by BMC, stands as a premier open-access platform dedicated to advancing the field of ophthalmology, specifically focusing on retina and vitreous research. Established in 2015, this journal has swiftly positioned itself within the academic community, achieving a commendable Q2 category ranking in Ophthalmology for 2023, and ranks #49 out of 137 in Scopus for Medicine - Ophthalmology, indicating its growing influence and reach within the scientific landscape. The journal is committed to disseminating high-quality research, reviews, and clinical insights that explore innovations, challenges, and breakthroughs in ocular health. With the goal of fostering knowledge exchange among researchers, practitioners, and students, the International Journal of Retina and Vitreous promotes an open-access model, ensuring that vital findings are readily available to a global audience. This journal not only serves as a vital resource for advancing the understanding and treatment of retinal and vitreous diseases but also aims to inspire future studies in this critical area of eye health.

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.